Wacker Biotech and RNAV8 Bio's collaboration advances mRNA-based therapies, merging manufacturing and mRNA engineering expertise. Wacker Biotech brings pharmaceutical-grade pDNA and protein production capabilities with high-capacity fermentation lines. RNAV8 Bio…
Dave Williamson leads innovations at Abzena, focusing on bioconjugates and ADCs to transform patient care globally. His diverse experiences, from the U.S. Army to pharmaceutical technology, fuel his passion for…
A strategic partnership between Wacker Biotech and RNAV8 Bio aims to revolutionize mRNA-based therapies. The collaboration focuses on optimizing untranslated regions (UTRs) in mRNA strands to enhance drug effectiveness. Improved…